HO CHI MINH CITY, Vietnam, Jan. 18, 2023 /PRNewswire/ -- Boehringer Ingelheim Vietnam has been honored  for the fourth year in succession for its outstanding employee benefits with emphasis on wellbeing, attractive work environment, and rewards and recognition. Globally, Boehringer Ingelheim has been awarded for the third year in succession a "Global Top Employer" by the Top Employers Institute, one of the world's 15 best employers.

The certification highlights the company's commitment to prioritizing mental health for employees, in addition to nurturing talents to instill a changemaker mindset.

Boehringer Ingelheim's employer offerings do particularly stand out in the dimensions of wellbeing, work environment, as well as rewards and recognition. The results reflect the company's holistic employee healthcare and wellbeing approach that, beyond its emphasis on mental health, integrates concepts of physical, social and financial health. Through dedicated programs and offers, its employees receive support that is relevant for them and their families. This includes a work environment of physical and emotional security, an inclusive way of working together creating a sense of belonging, mental health awareness initiatives and manager trainings, focus on work-life-balance, opportunities for volunteering, and competitive pay and benefits.

"We are honored to receive the recognition by the Top Employers Institute. This is a testament to our commitment to the well-being and growth of our employees. Boehringer Ingelheim is dedicated to creating a diverse and inclusive workplace through our established leadership development initiatives and extensive talent development programmes that bring out the best in our people. In these changing times, we remain dedicated to our people and ensure that they remain engaged, empowered and appreciated," said Ms. Cyndy Bautista-Galimpin, General Manager of Boehringer Ingelheim Vietnam.

Nurturing talent and instilling a growth mindset is driven throughout the organisations' key employee programmes with the aim to support broader skill sets development and create a fulfilling work environment. Some of these programmes include the Regional Talent Move programme which aims to build agility and resilience by allowing employees to take on a stretch assignment in a different country for up to six months to work on a project or business problem, and the B-effect project that is run in partnership with Ashoka, an international network focused on social entrepreneurship and teaches employees to create positive change and innovation by developing a change maker mindset using a six step process.

"We constantly challenge ourselves to raise the bar of our people's well-being and consistently invest in developing their skills and the value they can bring to the organisation and society. By doing so, our people are equipped with leadership and entrepreneurial skills to improve outcomes for patients and animals," said Ms. Cyndy Bautista-Galimpin.

Diversity, Equity and Inclusion (DEI) is identified as an integral part of the company's identity and a key element of the culture. Learning about this  importance, Boehringer Ingelheim Vietnam in November hosted the first event among other countries in the region for its employees to explore multiple aspects of DEI including social and economic status, gender balance for personal growth and development.

Boehringer Ingelheim has also stepped up its commitment to positively impact people, animals, communities, and the planet through key sustainability initiatives under 'Sustainable Development – For Generations" framework in Vietnam.

In the area of healthcare access, Boehringer Ingelheim is in partnership with the World Stroke Organization (WSO) and many other national stroke societies, companies, and health institutions to build an innovative network of stroke-ready hospitals and stroke centers. In Vietnam, there have been 120 hospitals with 98 stroke-ready hospitals until October 2022.

Under its Rabies Vaccination Program, Boehringer Ingelheim Vietnam has been vaccinating close to 6,400 dogs and cats in Long An province and working with local partners to build capacity and educate villages and students about the importance of self-protection and pet vaccination.

About Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.